HoneyNaps is collaborating with Korean and Swedish researchers to develop AI-powered neurological monitoring technology. The project also highlights HoneyNaps USA Managing Director Christine Kwon.
Browsing: neuroscience
Pathos AI has secured $237 million in financing and announced new partnerships focused on AI-powered research involving Alzheimer’s disease and other neurological conditions. Together, the announcements highlight growing investment in AI technologies designed to support scientific research and clinical development.